Filter
2620
Filtered Results: 2620
Text search:
vaccine
supply
Featured
Recommendations
298
New Publications
724
Language
Document type
No document type
1239
Studies & Reports
474
Guidelines
416
Strategic & Response Plan
176
Manuals
124
Fact sheets
83
Situation Updates
47
Training Material
36
Resource Platforms
13
Brochures
6
Online Courses
3
Infographics
2
App
1
Countries / Regions
India
123
Global
110
Kenya
79
Liberia
73
Nigeria
70
Sierra Leone
67
Ethiopia
61
Uganda
58
South Africa
49
Africa
44
Ghana
43
Nepal
42
Western and Central Europe
41
Congo, Democratic Republic of
39
Zambia
37
Malawi
36
Latin America and the Carribbean
33
Ukraine
32
Syria
32
Tanzania
32
Bangladesh
32
Myanmar / Burma
29
Rwanda
28
Philippines
22
Haiti
22
Guinea
21
West and Central Africa
21
Brazil
21
South Sudan
21
East and Southern Africa
20
Zimbabwe
19
Mozambique
19
South–East Asia Region
19
Russia
18
Yemen
18
Middle East and North Africa
17
Namibia
17
Senegal
16
Pakistan
16
Lesotho
15
Eastern Europe
15
Eastern Europe and Central Asia
13
Asia
12
Burkina Faso
11
Sudan
11
Cameroon
10
Cambodia
10
Botswana
10
Indonesia
10
Afghanistan
8
Venezuela
8
Western Pacific Region
8
Germany
7
Central African Republic
7
Somalia
6
Benin
5
Laos
5
Moldova
5
Mali
5
Eswatini/ Swaziland
5
Colombia
4
Paraguay
4
Lebanon
4
Chad
4
Thailand
3
Turkey
3
Togo
3
Jordan
3
Vietnam
3
Papua New Guinea
3
Iraq
3
Madagascar
3
North Macedonia
2
Timor Leste/ East Timor
2
China
2
Chile
2
Albania
2
Burundi
2
Peru
2
USA
2
Guinea-Bissau
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Sri Lanka
2
Georgia
2
Angola
2
Tajikistan
1
Mexico
1
Gambia
1
Canada
1
Fiji
1
Kyrgyzstan
1
Niger
1
Bulgaria
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
United Kingdom
1
Portugal
1
Spain
1
Libya
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1107
Clinical Guidelines
212
Public Health
128
Women & Child Health
124
Key Resources
105
Pharmacy & Technologies
40
Capacity Building
21
Annual Report MEDBOX
2
Toolboxes
COVID-19
468
Rapid Response
130
AMR
127
TB
121
HIV
115
Ebola
108
Pharmacy
82
Conflict
79
Planetary Health
60
Global Health Education
53
Caregiver
49
NTDs
46
Refugee
45
Health Financing Toolbox
45
Cholera
41
Polio
38
Natural Hazards
35
Mental Health
18
NCDs
14
Zika
14
Specific Hazards
8
Disability
8
Typhoon
3
Health Financing
2
South Sudan
1
Explainer for countries based on commonly asked questions
12 November 2020
This document aims to explain how COVAX vaccines will be allocated amongst participants.
The Access to COVID-19 Tools (ACT) Accelerator’s Country Readiness and Delivery workstream has released guidance on developing a national deployment and vaccination plan (NDVP) for COVID-19 vaccines. This course is intended to help national and sub-national focal points in countries develop the ND...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Create demand, promote acceptability and accessibility o...
For most people in displacement contexts, there are simply not enough vaccines available in the places where they are hosted: 85% of refugees are hosted in lower- and middle-income countries, while in the first six months of this year 85% of vaccines went to wealthy countries; lower- and middle inco...
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
This survey is part of a series of eight country surveys conducted in the context of the People that Deliver Initiative (peoplethatdeliver.org). This global initiative, which brings together the world’s largest organizations, aims to improve health services performance through the professionalizat...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
This policy brief draws from the latest evidence on the impact of vaccination program start date and vaccine rollout rates on health benefits. The objective is to support policymakers on decisions to procure COVID-19 vaccines and roll out vaccination programmes in countries, especially those
where ...
first issued 18 August 2022
